Kymera Therapeutics Inc. Common Stock vs Seaboard Corporation Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Seaboard Corporation Common Stock trades at $4,019 (market cap $3.80B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 2.3× Seaboard Corporation Common Stock's market cap, and Seaboard Corporation Common Stock pays a 0.23% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Seaboard Corporation Common Stock for 0 Days on average.
| KYMR | SEB | |
|---|---|---|
Market Cap | $8.87B | $3.80B |
Volume | 779,107 | 9,086 |
Sector | Health | Industrials |
52-Week High | $127.31 | $5.96K |
52-Week Low | $55.80 | $3.22K |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $4.57B |
Dividend Yield | — | 0.23% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Seaboard Corporation is a diversified agribusiness and transportation company operating through pork production, commodity trading and milling, marine cargo shipping, liquid fuels, power generation, and turkey production segments, including its Seaboard Foods and Butterball businesses. It operates across North America, the Caribbean, South America, Africa, and Europe.
Read more on SEB →